| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Head of North America
1 company
Lee Jennifer Kayden is an EVP, Head of North America at RYTM. Recent filings cover 0 purchases and 36 sales.
Our model assigns Lee Jennifer Kayden a below-average insider score of 35/100, based on 23 past trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -68.4%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 1, 2024 | RYTM Rhythm Pharmaceuticals, Inc. | EVP, Head of North America | Sale+OE | 1,492 | $45.06 | $67,229.52 | -33.1% | -10.6% | +28.3% | |
| Nov 14, 2023 | RYTM Rhythm Pharmaceuticals, Inc. | EVP, Head of North America | Sale+OE10b5-1 | 13,677 | $32.01 | $437,818.55 | - | +58.8% | +81.9% | |
| Nov 9, 2023 | RYTM Rhythm Pharmaceuticals, Inc. | EVP, Head of North America | Sale+OE10b5-1 | 9,150 | $28.45 | $260,287.45 | -84.7% | +77.4% | +149.9% | |
| Nov 3, 2023 | RYTM Rhythm Pharmaceuticals, Inc. | EVP, Head of North America | Sale+OE10b5-1 | 80 | $28.00 | $2,240.00 | -4.6% | +71.8% | +81.7% | |
| Sep 5, 2023 | RYTM Rhythm Pharmaceuticals, Inc. | EVP, Head of North America | Sale+OE10b5-1 | 6,166 | $28.05 | $172,957.53 | -78.9% | +36.3% | +83.9% | |
| Aug 9, 2023 | RYTM Rhythm Pharmaceuticals, Inc. | EVP, Head of North America | Sale+OE10b5-1 | 12,941 | $24.24 | $313,713.33 | -79.7% | +6.9% | +81.9% | |
| Feb 14, 2023 | RYTM Rhythm Pharmaceuticals, Inc. | EVP, Head of North America | Sale+OE | 635 | $26.87 | $17,062.45 | -11.4% | -38.1% | +83.5% | |
| Feb 9, 2023 | RYTM Rhythm Pharmaceuticals, Inc. | EVP, Head of North America | Sale+OE | 1,192 | $27.66 | $32,970.72 | -25.1% | -37.0% | +85.0% | |
| Feb 15, 2022 | RYTM Rhythm Pharmaceuticals, Inc. | EVP, Head of North America | Sale+OE | 722 | $6.10 | $4,404.20 | -35.5% | -52.6% | +288.2% |